Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity - Carrillo,J.A.; Dahl,M.L.; Svensson,J.O.; Alm,C.; Rodriguez,I.; Bertilsson,L. (Clin Pharmacol Ther, 1996)